Homepage
Author:
Grace Therapeutics, Inc.
Posted Date:
April 23, 2026
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
Grace Therapeutics, Inc.
April 23, 2026
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Grace Therapeutics, Inc.
April 14, 2026
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
Grace Therapeutics, Inc.
March 19, 2026
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Grace Therapeutics, Inc.
February 25, 2026
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
Grace Therapeutics, Inc.
February 12, 2026
